Cargando…
The effects and mechanisms of a biosynthetic ginsenoside 3β,12β-Di-O-Glc-PPD on non-small cell lung cancer
BACKGROUND: A biosynthetic ginsenoside, 3-O-β-D-glucopyranosyl-12-O-β-D-glucopyranosyl-dammar-24-ene-3β, 12β, 20S-triol (C(3)C(12)PPD), showed antitumor activity against many tumor cells in vitro, especially had better anti-lung cancer activity than Rg3 in vitro and in vivo. However, the effects and...
Autores principales: | Huang, Lu-Lu, Tang, Mei, Du, Qian-Qian, Liu, Chun-Xia, Yan, Chen, Yang, Jin-Ling, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750213/ https://www.ncbi.nlm.nih.gov/pubmed/31571900 http://dx.doi.org/10.2147/OTT.S217039 |
Ejemplares similares
-
Metabolic engineering of yeasts for green and sustainable production of bioactive ginsenosides F2 and 3β,20S-Di-O-Glc-DM
por: Jiang, Fenglin, et al.
Publicado: (2022) -
Hexosamine biosynthetic pathway and O-GlcNAc-processing enzymes regulate daily rhythms in protein O-GlcNAcylation
por: Liu, Xianhui, et al.
Publicado: (2021) -
Ginsenoside PPD’s Antitumor Effect via Down-Regulation of mTOR Revealed by Super-Resolution Imaging
por: Teng, Bo, et al.
Publicado: (2017) -
Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation
por: Hu, Jie, et al.
Publicado: (2021) -
Hexosamine Biosynthetic Pathway-Derived O-GlcNAcylation Is Critical for RANKL-Mediated Osteoclast Differentiation
por: Kim, Myoung Jun, et al.
Publicado: (2021)